GEMC1-MCIDAS transcriptional program regulates multiciliogenesis in the choroid plexus and acts as a barrier to tumorigenesis
Qun Li,Zhiyuan Han,Navleen Singh,Berta Terré,Ryann M. Fame,Uzayr Arif,Thomas D. Page,Tasneem Zahran,Ahmed Abdeltawab,Yuan Huang,Ping Cao,Jun Wang,Hao Lu,Hart G.W. Lidov,Kameswaran Surendran,Lizhao Wu,Ulrich Schüller,Robert J. Wechsler-Reya,Maria K. Lehtinen,Sudipto Roy,Zhongmin Liu,Travis H. Stracker,Haotian Zhao
DOI: https://doi.org/10.1101/2020.11.22.393298
2020-01-01
Abstract:Multiciliated cells (MCCs) in the brain include the ependymal cells and choroid plexus (CP) epithelial cells. The CP secretes cerebrospinal fluid that circulates within the ventricular system, driven by ependymal cilia movement. However, the mechanisms and functional significance of multiciliogenesis in the CP remain unknown. Deregulated oncogenic signals cause CP carcinoma (CPC), a rare but aggressive pediatric brain cancer. Here we show that aberrant NOTCH and Sonic Hedgehog signaling in mice drive tumors that resemble CPC in humans. NOTCH-driven CP tumors were monociliated, whereas disruption of the NOTCH complex restored multiciliation and decreased tumor growth. NOTCH suppressed multiciliation in tumor cells by inhibiting the expression of GEMC1 and MCIDAS, early regulators of multiciliogenesis. Consistently, GEMC1-MCIDAS function is essential for multiciliation in the CP, and is critical for correcting multiciliation defect in tumor cells by a NOTCH inhibitor. Disturbances to the GEMC1 program are commonly observed in human CPCs characterized by solitary cilia. Consistently, CPC driven by deletion of Trp53 and Rb1 in mice exhibits a cilia deficit consequent to loss of Gemc1-Mcidas expression. Taken together, these findings reveal a GEMC1-MCIDAS multiciliation program in the CP critical for inhibiting tumorigenesis, and it may have therapeutic implications for the treatment of CPC.
### Competing Interest Statement
The authors have declared no competing interest.